Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents
US7795299B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2009 |
| Grant date | Sep 14, 2010 |
| Priority date | — |
| Expiry date | Jan 16, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of Formulas I-II are described,along with methods of using such compounds for the treatment of cancer and pharmaceutical formulations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.